Mainstay Medical, Biotech Firm Out Of Ireland, Selects Little Italy For U.S Headquarters

San Diego CA

17 August, 2021

11:43 AM

Description

By Editor, Times of San Diego August 17, 2021 Mainstay Medical, an Ireland-based medical device company, will become the first biotech firm to relocate to the downtown San Diego area, according to the commercial real estate firm CBRE. Evan Knudson and Michael Peterson of CBRE represented the landlord, H.G. Fenton Company, in the transaction. Mainstay Medical, based in Dublin, will use 23,136 square feet of space in Little Italy as their U.S. headquarters. The building, at 2171 India St., is part of a project featuring a mix of office, retail and dining. The medical firm, according to CBRE, plans to perform both office functions and light manufacturing out of the location. "This is a landmark deal for downtown San Diego that builds on the momentum of recent large-scale investments in the life science space by IQHQ and Phase 3," Knudson said. "Mainstay Medical's new U.S. headquarters in Little Italy was chosen for its European and urban feel, walkable amenities and close proximity to the airport and mass transit." Peterson noted the strength of the biotech and life science industries in other parts of the county, and the promise of that sector in more urban areas of the city. "Mainstay Medical will be the first of many biotech firms to enjoy all of the amenities that downtown and Little Italy have to offer," he said. He also credited H.G. Fenton with cultivating "the growth of Little Italy." "From the development of Piazza della Famiglia to this first-to-market biotech use, H.G. Fenton continues to add value to the vibrant Little Italy neighborhood," Peterson said. Times of San Diego is an independent online news site covering the San Diego metropolitan area. Our journalists report on politics, crime, business, sports, education, arts, the military and everyday life in San Diego. No subscription is required, and you can sign up for a free daily newsletter with a summary of the latest news.